As of Feb 27
| -0.79 / -1.71%|
The 2 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 43.00, with a high estimate of 49.00 and a low estimate of 37.00. The median estimate represents a -5.29% decrease from the last price of 45.40.
The current consensus among 2 polled investment analysts is to Buy stock in Cantel Medical Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.